Browsing Tag
Hemlibra
3 posts
Roche (SIX: ROP) sales rise 7% as pipeline hopes meet a near-record valuation
Roche delivered 7% constant-currency Q3 sales growth and maintained 2026 guidance as newer medicines offset patent erosion. With ROP touching a 52-week high and key medicines still awaiting regulatory decisions, pipeline conversion is becoming the next valuation test.
Alvotech (Nasdaq: ALVO) lands $150m Lotus biosimilar deal across US, Asia
The deal covers proposed biosimilars to Imfinzi and Hemlibra, whose reference products generated about $11.9 billion of combined 2025 global sales.
Novo Nordisk seeks FDA nod for Mim8 — how will this impact hemophilia treatment and NVO stock?
Novo Nordisk files FDA application for Mim8 in hemophilia A. Learn how flexible dosing and trial data could redefine the bleeding disorder market.